NICE says no to elderly discrimination

NICE rejects the government’s plans to link drug funding to societal benefit amid fears of discrimination.

Musgrove Park Hospital joins national prostate imaging trial

New state-of-the-art prostate biopsies are now offered at Musgrove Park Hospital as part of a national study.

Powerful pair to battle NHS hospital failings

Health secretary Jeremy Hunt has called on two powerful leaders to review NHS hospital management and improve standards of care.

No more bodged botox

The Department of Health has outlined various new interventions to protect patients undergoing cosmetic surgery.

‘Inappropriate’ financial penalties scrapped for new fund

The Department of Health will not be financially penalising commissioners failing to meet their targets when spending the Better Care fund.

We need more money, say GPs

The Royal College of GPs has called for increased budgets for GPs as underfunding ‘compromises patient care’.

Friend or foe?

The debate over the risks and benefits of the NHS’ medical record database scheme continues.

Patients may be charged for cancer treatment

Experts have warned that NHS budget issues could translate into patient cancer treatment charges.

A ‘tangible shift’ in the NHS in a year?

Jeremy Hunt commended the ‘tangible shift’ in the NHS in the year since the hospital scandals were revealed in the Francis report, vowing to ‘go even further’.

Let down by the one you love – CQC chair calls for ‘serious change’

David Prior, CQC chairman, suggests “serious change” is necessary to ensure the survival of his 'beloved' NHS.

Latest articles

Image of a contract being signed by two people with a certification stamp to show European Commission approves extended Invokana ® (canagliflozin) indication

European Commission approves extended Invokana ® (canagliflozin) indication

The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Image of hands signing a contract to show EC approves Janssen's preventative Ebola vaccine

EC approves Janssen’s preventative Ebola vaccine

Johnson & Johnson has announced that the European Commission (EC) has granted Marketing Authorisation for Janssen’s preventive Ebola vaccine. This marks the first major...
Image of a mac and desk setup to show Pf Webinars: Shaping healthcare markets to serve real brand purpose

Pf Webinars: Shaping healthcare markets to serve real brand purpose

Pf's third FREE webinar in conjunction with Triducive and E4H focuses on shaping healthcare markets to serve real brand purpose. As healthcare markets are evolve...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a hand holding a torch to show Kate Bingham appointed Chair of UK Vaccine Taskforce

Kate Bingham appointed Chair of UK Vaccine Taskforce

Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Image of a healthcare professional in PPE with medical equipment and rip to show No clear benefit of HIV antivirals for COVID-19 patients

No clear benefit of HIV antivirals for COVID-19 patients, says study

There is no clear benefit of HIV antivirals for COVID-19 patients, says new study by the Drug Safety Research Unit (DSRU) in Southampton. It...
Image of a contract being signed by two people with a certification stamp to show European Commission approves extended Invokana ® (canagliflozin) indication

European Commission approves extended Invokana ® (canagliflozin) indication

The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription